XML 19 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity
 12 Months Ended
Jan. 03, 2020
Stockholders Equity Note [Abstract]  
Stockholders' Equity

Note 8: Stockholders’ Equity

Preferred Stock

The Company has authorized 2,000,000 shares of undesignated preferred stock with a par value of $0.001 per share. None of the preferred shares were issued and outstanding at January 3, 2020 and December 28, 2018.

Dividends

The Company declared and paid cash dividends per common share during the periods presented as follows:

 

 

 

Fiscal Years

 

 

 

2019

 

 

 

Dividends

 

 

Amount

 

 

 

Per Share

 

 

(in thousands)

 

First Quarter

 

$

0.160

 

 

$

8,240

 

Second Quarter

 

$

0.160

 

 

 

8,306

 

Third Quarter

 

$

0.160

 

 

 

8,323

 

Fourth Quarter

 

$

0.160

 

 

 

8,280

 

 

 

 

 

 

 

$

33,149

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years

 

 

 

2018

 

 

 

Dividends

 

 

Amount

 

 

 

Per Share

 

 

(in thousands)

 

First Quarter

 

$

0.130

 

 

$

6,700

 

Second Quarter

 

$

0.130

 

 

 

6,764

 

Third Quarter

 

$

0.130

 

 

 

6,765

 

Fourth Quarter

 

$

0.130

 

 

 

6,723

 

 

 

 

 

 

 

$

26,952

 

Treasury Stock

Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $5,146,000, $5,892,000 and $5,667,000 were recorded as a reduction to retained earnings during 2019, 2018 and 2017, respectively.

Repurchase of Common Stock

The Company repurchased 342,000 shares of its common stock for $21,957,000 during 2019. The Company repurchased 562,000 shares of its common stock for $27,915,000 during 2018. The Company repurchased 372,000 shares of its common stock for $11,931,000 during 2017. On January 31, 2019 the Board of Directors authorized $75,000,000 for the repurchase of Exponent’s common stock. On October 19, 2016 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’s common stock. These repurchase programs have no expiration dates. As of January 3, 2020, the Company had remaining authorization under its stock repurchase plan of $70,504,000 to repurchase shares of common stock.